Nonetheless, to date the only FDA- and EMA-approved NRF2 activator for the treatment of relapsing-remitting MS and psoriasis is DMF, and its therapeutic potential in ALS patients in terms of efficacy, safety and tolerability, is now being evaluated in a phase-II clinical trial [313]
This condition exists in two main forms: non-alcoholic fatty liver disease (NAFLD) , which affects individuals who drink little or no alcohol, and alcohol-related liver disease (ARLD) , caused by excessive alcohol consumption
Campone, M., et al
Eight respiratory conditions: stable COPD, acute exacerbations of COPD (AECOPD), tuberculosis (TB), and anti-tubercular druginduced liver injury (AT-DILI), non-cystic fibrosis bronchiectasis, cystic fibrosis (CF), bacterial and viral infections, interstitial lung disease (ILD), and asthma were studied and discussed
Promoting Metabolism 1
Published on October 24th, 2025